Category Archives: Cell Medicine

Bar Harbor – Yijun Ruan, Ph.D., an American geneticist who has pioneered new techniques to sequence and map DNA to better understand cancer growth and stem cell properties, will be the first scientist to join the new Jackson Laboratory for Genomic Medicine (JAX Genomic Medicine) in Farmington, Conn. Ruan is currently associate director and senior group leader at the Genome Institute of Singapore and professor of biochemistry at the National University of Singapore. He is also an investigator with the Encyclopedia of DNA Elements (ENCODE) project, an international consortium of research groups funded by the National Human Genome Research Institute. Ruan said he was attracted by The Jackson Laboratory’s famously collaborative research environment, and plans to “take a community approach to tackle genomic questions through intensive collaboration.” Through innovating new technologies and studying how the human and mouse genomes are regulated, he said his goal is to translate research findings into personalized medicine. Ruan has also been appointed director of JAX Genomic Sciences, and will be bringing his current research program and team with him to JAX Genomic Medicine. JAX Genomic Medicine will unite doctors, patients, scientists and industry to find new ways to tailor disease diagnosis, prevention and treatment … Continue reading →

Newswise — The International Society for Stem Cell Research (ISSCR) is pleased to announce the winner of the 2012 McEwen Award for Innovation, a coveted prize in the field of stem cell research and regenerative medicine. The 2012 recipient is Rudolf Jaenisch, MD, Founding Member of the Whitehead Institute for Biomedical Research and Professor of Biology at the Massachusetts Institute of Technology in recognition of his pioneering discoveries in the areas of genetic and epigenetic control of development in mice that directly impact the future potential of embryonic stem cells and induced pluripotent stem cells for therapeutic utility. The McEwen Award for Innovation is supported by the McEwen Centre for Regenerative Medicine in Toronto, Ontario, Canada. The $100,000 award honors original thinking and groundbreaking research pertaining to stem cells or regenerative medicine that opens new avenues of exploration towards the understanding or treatment of human disease or affliction. “Rudolf Jaenisch has consistently contributed new and groundbreaking discoveries to stem cell biology and regenerative medicines that have changed the way stem cell research is conducted, said Fred H. Gage, PhD, ISSCR President. “Importantly, Rudolf not only has an uncanny sense of the next big question, but also conducts his experiments with … Continue reading →

22-02-2012 05:16 Waisan Poon, Chinese U, Hong Kong, speaking on, "Clinical trial of umbilical cord blood stem cells in spinal cord injury" at the International Conference of Stem Cells and Regenerative Medicine for Neurodegenerative Diseases to be held at the Tzu-Chi Hospital in Hualien, Taiwan on April 22-24, 2010. View original post here: Waisan Poon, "Clinical trial of umbilical cord blood stem cells in spinal cord injury" - Video … Continue reading →

22-02-2012 05:16 Waisan Poon, Chinese U, Hong Kong, speaking on, "Clinical trial of umbilical cord blood stem cells in spinal cord injury" at the International Conference of Stem Cells and Regenerative Medicine for Neurodegenerative Diseases to be held at the Tzu-Chi Hospital in Hualien, Taiwan on April 22-24, 2010. View original post here: Waisan Poon, "Clinical trial of umbilical cord blood stem cells in spinal cord injury" - Video … Continue reading →

Global leader in animal stem cell technology is poised for significant expansion through new partnership with top U.S. companion animal health distribution company. Las Vegas, Nevada (PRWEB) February 22, 2012 MediVet-America, the global leader in veterinary stem cell technology and regenerative medicine, has entered into a distribution partnership with Butler Schein Animal Health, a division of Henry Schein, the leading companion animal health distribution company in the U.S., to sell and distribute stem cell kits and equipment to veterinarians serving the nation’s fast-growing $50 billion pet industry. The announcement was made today at the Western Veterinary Conference in Las Vegas by Jeremy Delk, CEO of MediVet-America. The two companies will partner to sell and distribute MediVet-America’s advanced stem cell technology to more than 26,000 veterinary clinics nationwide. Adult animal stem cell technology uses the body’s own regenerative healing power to help treat dogs, cats, horses and other animals suffering from painful arthritis, hip dysplasia and tendon, ligament and cartilage injuries and other ailments. The Adipose-Derived Stem Cell Procedure Kit and state of the art equipment, co-developed with Medical Australia, enable veterinarians to remove a small sample of fat, separate the stem cells, then activate and inject them into affected areas. … Continue reading →

Global leader in animal stem cell technology is poised for significant expansion through new partnership with top U.S. companion animal health distribution company. Las Vegas, Nevada (PRWEB) February 22, 2012 MediVet-America, the global leader in veterinary stem cell technology and regenerative medicine, has entered into a distribution partnership with Butler Schein Animal Health, a division of Henry Schein, the leading companion animal health distribution company in the U.S., to sell and distribute stem cell kits and equipment to veterinarians serving the nation’s fast-growing $50 billion pet industry. The announcement was made today at the Western Veterinary Conference in Las Vegas by Jeremy Delk, CEO of MediVet-America. The two companies will partner to sell and distribute MediVet-America’s advanced stem cell technology to more than 26,000 veterinary clinics nationwide. Adult animal stem cell technology uses the body’s own regenerative healing power to help treat dogs, cats, horses and other animals suffering from painful arthritis, hip dysplasia and tendon, ligament and cartilage injuries and other ailments. The Adipose-Derived Stem Cell Procedure Kit and state of the art equipment, co-developed with Medical Australia, enable veterinarians to remove a small sample of fat, separate the stem cells, then activate and inject them into affected areas. … Continue reading →

21-02-2012 17:22 THIS VIDEO BELONGS TO THOSE THAT PRODUCED IT. IT IS NOT MINE AT ALL. I AM HONORED TO BE ALLOWED TO COPY AND PROMOTE IT. The latest and greatest information on getting everything from your medical marijuana this info will separate the patients from the pot heads, or those that claim to need pot when they are really just looking for a reason and excuse to get high, which is fine but I think they are slowing the real patients down from getting access and being seen as serious with their underlying greed. the big shock is that the dreaded male plant leaves have near the same medicinal qualities as the female. the female bud does have higher concentrations and I wont deny that fact. However the bottom line.... juicing the leaves in a good quality juicer is what this is really all about. The key to this is juicing fresh leaf and not allowing it to dry. this applies to the bud or flower as well. you can eat fresh bug and not get high, which is a shock, but it is true. To the two people that shared this information with me and took time to … Continue reading →

Public release date: 21-Feb-2012 [ | E-mail | Share ] Contact: Dr. Ian Zagon isz1@psu.edu Society for Experimental Biology and Medicine Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that the presence and integrity of the opioid growth factor receptor (OGFr), which mediates the inhibitory action of opioid growth factor (OGF) on cell proliferation, is a key to understanding the progression and treatment of human ovarian cancer. Transplantation of human ovarian cancer cells that were molecularly engineered to have a reduced expression of OGFr, into immunocompromised mice resulted in ovarian tumors that grew rapidly. This discovery, reported in the February 2012 issue of Experimental Biology and Medicine, provides fresh new insights into the pathogenesis and therapy of a lethal cancer that is the fifth leading cause of cancer-related mortality among women in the USA, and has a death rate that is unchanged for over 75 years. The OGF (also-termed [Met5]-enkephalin)-OGFr axis plays a fundamental role in cancer, development, and cellular renewal by regulating cell proliferation. An important question addressed in this study relates to the requirement of this peptide-receptor system for the progression of carcinogenesis. Human ovarian cancer cell lines that were genetically modified to … Continue reading →

Dr. Renato Dulbecco, an Italian American virologist who shared the 1975 Nobel Prize in physiology or medicine for demonstrating how certain types of viruses invade mammalian cells to cause cancer, died of natural causes Sunday at his home in La Jolla. He was 97. Dulbecco developed a method for measuring the quantity of virus in animal cells in tissue culture, a finding that greatly facilitated the study of such viruses and paved the way for the development of the Sabin polio vaccine. He was a faculty member at Caltech from 1949 to 1963 before moving to the Salk Institute for Biological Studies in La Jolla. He later served as president of the institute. Dulbecco was also one of the first proponents of the human genome project, which many researchers initially thought would be both excessively expensive and relatively useless but which has since proved invaluable in biological research. "Renato was one of the most brilliant scientific minds of our generation," current Salk Institute President William R. Brody said in a statement. "His contributions have truly made this a better world for all of us." It has been known since the early 1900s that certain viruses can cause tumors in animals. … Continue reading →

ROME (AP) — Renato Dulbecco, who shared the 1975 Nobel Prize in medicine for his seminal research on the interaction between tumors and cells, has died in California. He was 97. Dulbecco, an early proponent of sequencing genomes that led to the Human Genome Project, died in La Jolla, California overnight, Italy's National Research Council — where Dulbecco worked on the genome project in the 1990s — said Monday. Dulbecco was a founding fellow of the La Jolla-based Salk Institute for Biological Studies, where he was an emeritus president and distinguished professor. He moved from Italy to California early in his career, working first at Caltech in 1949, then at Salk in 1962, and then onwards to England, where he worked at the Imperial Cancer Research Fund Laboratories in London from 1972-1977. Dulbecco — who would have been 98 on Wednesday — shared the Nobel prize in medicine in 1975 along with David Baltimore and Howard Martin Temin "for their discoveries concerning the interaction between tumor viruses and the genetic material of the cell" according to the Nobel committee. His prize-winning research gave the first clue to the genetic nature of cancer, showing how a virus could insert its own … Continue reading →